| Vol. 11.41 – 17 October, 2023 |
| |
|
|
| The authors developed a platform of probiotic-guided CAR-T cells, in which tumor-colonizing probiotics released synthetic targets that labeled tumor tissue for CAR-mediated lysis in situ. [Science] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers performed single-cell RNA-sequencing of tumors from patients with esophageal squamous cell carcinoma undergoing neoadjuvant immune checkpoint blockade, revealing a subset of exhausted CD8+ T cells expressing SPRY1 that displayed a progenitor exhausted T cell phenotype. [Cancer Cell] |
|
|
|
| Scientists performed longitudinal immunophenotypic and functional analysis of pre- and on-treatment peripheral blood samples from patients in the Phase III E1912 trial comparing ibrutinib-rituximab to fludarabine, cyclophosphamide, and rituximab. [Blood] |
|
|
|
| Immunologic properties of the skin were analyzed by immunofluorescence staining, bulk and single-cell RNA and TCR sequencing, and a highly multiplex imaging technique known as CO-Detection by indEXing. [Journal Of Clinical Investigation] |
|
|
|
| Researchers performed clinical monitoring and comprehensive assessment of peripheral and allograft tissue immune cell populations in regulatory dendritic cells-infused live-donor liver transplant recipients up to 12 months after transplant. [Science Translational Medicine] |
|
|
|
| Investigators used fluorophore-conjugated HLA-DR tetramers containing citrullinated peptides from human cartilage intermediate layer protein, fibrinogen, vimentin, or enolase 1 to track cognate CD4+ T cells. [Journal Of Experimental Medicine] |
|
|
|
| A 89Zr-labeled CD8-targeted minibody was used with total-body positron emission tomography (PET) in healthy individuals and COVID-19 convalescent patients. Kinetic modeling results aligned with T cell–trafficking effects expected in lymphoid organs. [Science Advances] |
|
|
|
| In a prospective cohort of 195 immune-deficient/disordered people and 35 healthy volunteers, antispike immunoglobulin G (IgG) was detected in 88% of immune-deficient/disordered people after dose two, increasing to 93% by six months after dose three. [Science Advances] |
|
|
|
| In this observational cohort study, investigators collected serum and peripheral blood samples from 34 consecutive cancer patients with neurologic immune-related adverse events (irAE-n) during acute illness, and 49 cancer control patients without irAE-n. [Neuro-Oncology] |
| |
|
|
|
| Scientists discuss key similarities and differences in the regulation and function of stem-like exhausted CD8+ T cells and memory CD8+ T cells, and consider their context-specific contributions to protective immunity in diverse outcomes of cancer. [Nature Reviews Cancer] |
|
|
|
| The authors focus on T cells as key effectors of anti-cancer immunity and argue that cancer cells evade immune destruction by gaining control over pathways that usually serve to maintain physiological tolerance to self. [Immunity] |
|
|
|
| Scientists review the complex roles of B cells in metastasis, delineating the heterogeneity of B cell activity and subtypes by metastatic site, antibody class, antigen, and molecular phenotype. [Cancer Research] |
|
|
|
|
| A look at interim data on nanrilkefusp alfa, also known as SOT101, has revealed “insufficient efficacy to warrant further development in larger randomized trials” in the settings targeted to date, prompting Sotio to immediately stop enrollment in three studies. [Fierce Biotech] |
|
|
|
|
| November 11 – 15, 2023 Nashville, Tennessee, United States |
|
|
|
|
|
| Harvard Medical School – Boston, Massachusetts, United States |
|
|
|
| Berlin Institute of Health at Charité – Berlin, Germany |
|
|
|
| Cedars-Sinai – Los Angeles, California, United States |
|
|
|
| University of Turku – Turku, Finland |
|
|
|
| Institut Necker Enfants-Malades – Paris, France |
|
|
|
|